Lakewood-Amedex Biotherapeutics Supports Reintroduction of the PASTEUR Act and Focus on Combating Antimicrobial Resistance

Go back to Lakewood-Amedex Biotherapeutics Supports Reintroduction of the PASTEUR Act and Focus on Combating Antimicrobial Resistance
(NASDAQ: LABT) Delayed: 2.01 +0.02 (1.01%)
Previous Close $1.99    52 Week High
Open $1.99    52 Week Low
Day High $2.08    P/E N/A 
Day Low $1.92    EPS
Volume 328,354